0:00 0:00 1x

This is read by an automated voice. Please report any issues or inconsistencies here .

WASHINGTON — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.

United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully at NYU Langone Health.

It’s the latest step in the quest for animal-to-human transplants. A second U.S. company, eGenesis, is preparing to begin its own pig kidney clinical trial in the coming months. These are the first known clinical trials of what is called xenotransplantation in the world.

To protect the study participant’s identity, researchers aren’t releasing information about when the NYU surgery was perf

See Full Page